Drug profile · INN
cerivastatin sodium
BAYCOL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cerivastatin sodium (BAYCOL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN cerivastatin sodium
Brand BAYCOL
Route ORAL
Formulation TABLET
Frequently asked questions
What is cerivastatin sodium?
cerivastatin sodium (BAYCOL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cerivastatin sodium?
BAYCOL is a marketed brand name for cerivastatin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cerivastatin sodium?
cerivastatin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.